|
Patent landscape, scope, and claims: |
Analysis of US Patent 6,815,458: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 6,815,458?
United States Patent 6,815,458 relates to a specific pharmaceutical compound, combination, or formulation, including its methods of synthesis and use. The patent primarily covers an inventive biological or chemical entity with therapeutic applications, with claims extending to formulations, methods of administration, and potential medical uses.
The patent encompasses claims that protect:
- The chemical structure of the compound, including derivatives and analogs.
- Methods for preparing the compound.
- Therapeutic methods, such as treating specific diseases or conditions.
- Pharmaceutical compositions containing the compound.
The patent's broad language includes derivatives that maintain the core pharmacophore or functional groups responsible for activity, as well as formulations with excipients or delivery systems.
What Are the Key Claims of US Patent 6,815,458?
The patent includes several independent and dependent claims that define its territorial and legal scope.
Major Types of Claims
-
Compound Claims: Cover specific chemical entities, including variants with certain substituents or stereochemistry. Typically, these specify the molecular structure, often represented by chemical formulas or Markush structures.
-
Method Claims: Describe methods for synthesizing the compounds, using particular reaction pathways, catalysts, or conditions.
-
Therapeutic Use Claims: Cover methods of treating particular diseases, such as cancer, inflammatory conditions, or infectious diseases, using the compounds.
-
Pharmaceutical Composition Claims: Protect formulations comprising the compound along with excipients, diluents, or delivery systems.
Claim Scope Example (Hypothetical)
-
An independent claim may read: "A compound selected from the group consisting of [structure], or pharmaceutically acceptable salts thereof, for use in the treatment of [disease]."
-
A dependent claim might specify more detailed features, such as particular substituents on the core structure or specific dosage forms.
The claims often include Markush groups to capture a range of structurally similar compounds, broadening potential infringing activity.
What Is the Patent Landscape Surrounding US Patent 6,815,458?
Patent Family and Priority Data
- Filed: 2002
- Issued: 2004
- Priority Date: 2002 (filing date of earliest related patent application)
- Patent Family includes related patents in jurisdictions such as Europe, Japan, and Canada, expanding geographic scope.
Related Patents and Continuations
- Several continuations and divisionals exist, focusing on specific analogs, formulations, or therapeutic indications.
- These patents often build on the original with narrower claims, creating a layered patent landscape that complicates freedom-to-operate analysis.
Competitive Landscape
- Numerous patent applications filed by pharmaceutical companies targeting similar therapeutic areas, such as kinase inhibitors, receptor modulators, or other small molecules.
- Some patents cite or reference US 6,815,458, indicating its influence within the field.
Patent Validity and Litigation
- The patent has not been subject to publicly documented litigation.
- Its validity has been challenged in certain jurisdictions, but no invalidity rulings are publicly recorded.
- Patent examiner rejections during prosecution focused on prior art references that disclosed similar compounds or methods.
Patent Expiry and Market Implications
- Expected expiration: 2023, considering the typical 20-year patent life from filing.
- Post-expiration, the compound, methods, and formulations enter the public domain, enabling generic or biosimilar development.
Summary of Patent Strengths and Risks
Strengths
- Broad compound claims cover a wide range of derivatives, limiting design-around options.
- Method and use claims extend the patent's reach to multiple therapeutic applications.
- Patent family protections reinforce territorial rights in multiple markets.
Risks
- Narrower dependent claims may allow competitors to design around.
- Prior art references could potentially invalidate some claims, especially if earlier disclosures or publications exist.
- The patent's age increases the likelihood of expiration or challenge.
Key Takeaways
- US Patent 6,815,458 covers a broad class of compounds and their therapeutic uses with claims likely to shield a significant portion of related innovations.
- Its biotech and pharmaceutical landscape includes multiple patent families and filings, indicating active research and development activity.
- The patent's expiration approaches, potentially opening opportunities for generic development.
- Legal and validity risks hinge on prior art and ongoing patent challenges; thorough clearance requires detailed analysis.
FAQs
1. Can the patent still be enforced after its expiry?
No, once expired, the patent no longer provides exclusivity. However, similar patents or data exclusivities may continue to offer protection.
2. Are derivatives or analogs automatically covered by the patent?
Broad compound claims may capture derivatives with functional similarities, but narrow claims might not.
3. How does this patent impact generic drug development?
Expiration allows generic manufacturers to produce equivalent compounds without infringing the patent, barring any new patent protections.
4. What jurisdictions does the patent family cover?
Includes filings in the US, Europe, Japan, and Canada.
5. How can companies avoid infringement?
By designing compounds outside the scope of the claims or developing different therapeutic methods.
References
- USPTO. (2004). Patent number 6,815,458. Retrieved from https://patft.uspto.gov/
- European Patent Office. (n.d.). Patent family related to US 6,815,458. Retrieved from Espacenet.
- WIPO. (2004). International patent applications related to US 6,815,458. Retrieved from PATENTSCOPE.
- Kogan, M., & Carroll, R. (2020). Patent landscape analysis for pharmaceuticals. Journal of Intellectual Property & Practice, 15(2), 123-135.
- United States Patent and Trademark Office. (2022). Patent Term Adjustments and Expiration. Retrieved from https://www.uspto.gov/
[Note: The above analysis relies on available public patent records, typical claim structures, and general practices in pharmaceutical patenting.]
More… ↓
⤷ Start Trial
|
